Michael Wells, MD
Family Medicine · Louisville, KYNPI 1831482454
Payments from drug & device makers
Across 161 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$609
- Novo Nordisk$329
- GSK$287
- AstraZeneca$216
- Amgen$208
- Abiomed$125
- plus $754 from 22 others
What the payments were for
- Food & beverage$2,528100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $609 |
| Novo Nordisk | 23 | $329 |
| GSK | 22 | $287 |
| AstraZeneca(2 entities) | 16 | $216 |
| Amgen | 13 | $208 |
| Abiomed | 1 | $125 |
| Amarin Pharma, Inc. | 6 | $95 |
| Exact Sciences | 6 | $94 |
| Stryker | 1 | $62 |
| Kowa Pharmaceuticals America, Inc. | 3 | $50 |
| Pfizer | 3 | $45 |
| Lilly USA, LLC | 3 | $42 |
| Johnson & Johnson | 3 | $42 |
| Astellas Pharma US Inc | 3 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Dexcom, Inc. | 2 | $28 |
| Bayer | 2 | $28 |
| Esperion Therapeutics, Inc. | 2 | $27 |
| Sanofi Pasteur Inc. | 2 | $26 |
| Merck | 2 | $23 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Novartis | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Radius Health, Inc. | 1 | $12 |
| Lifescan, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$125
How this compares
$2,528 in reported general payments places this provider in the 70th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 76 | $81,918 |
| JardianceEmpagliflozin | 62 | $77,877 |
| JanuviaSitagliptin Phosphate | 44 | $60,502 |
| XareltoRivaroxaban | 22 | $34,222 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $23,256 |
| OzempicSemaglutide | 16 | $19,970 |
| LinzessLinaclotide | 19 | $16,151 |
| MyrbetriqMirabegron | 30 | $14,121 |
| Spiriva RespimatTiotropium Bromide | 13 | $7,749 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $7,519 |
| Atorvastatin Calcium | 611 | $4,706 |
| Fluticasone Propionate | 78 | $4,368 |
| Levothyroxine Sodium | 401 | $4,287 |
| SynthroidLevothyroxine Sodium | 83 | $3,147 |
| Ezetimibe | 124 | $3,044 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $15 | $85,62775 claims |
| PfizerEliquis | $45 | $81,91876 claims |
| MerckJanuvia | $23 | $60,50244 claims |
| Johnson & JohnsonXarelto | $42 | $34,22222 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $287 | $30,77643 claims |
| Novo NordiskOzempic | $329 | $19,97016 claims |
| AbbVieLinzess, Synthroid | $609 | $19,298102 claims |
| Astellas Pharma US IncMyrbetriq | $40 | $14,12130 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $4,287401 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Louisville
- Christopher RhyneLouisville$1M
- Michael LovelaceLouisville$244K
- Suraj GathaniLouisville$69K
- Mandy WhittLouisville$38K
- Michael PendletonLouisville$29K
- Rajanbhai AminLouisville$26K
- James WrightLouisville$18K
- Rosenberg ReyesLouisville$18K
- Dennis GrayLouisville$14K
- Vincent LangLouisville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.